Viewing StudyNCT01324258



Ignite Creation Date: 2024-05-05 @ 11:26 PM
Last Modification Date: 2024-10-26 @ 10:33 AM
Study NCT ID: NCT01324258
Status: COMPLETED
Last Update Posted: 2017-11-13
First Post: 2011-01-22

Brief Title: Trial of GSK1120212 and GSK1120212 in Combination With GEM in Japanese Subjects With Solid Tumors
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Solid Tumours
Keywords:
Name View
urothelial cancer combination with gemcitabine View
pancreatic cancer combination with gemcitabine View
Non-small cell lung cancer combination with gemcitabine View
solid tumors single agent View
MEK inhibitor View
GSK1120212 View
biliary cancer combination with gemcitabine View